Spark Investment Management LLC Alnylam Pharmaceuticals, Inc. Transaction History

Spark Investment Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 12, 2019	SELL	$70.9 - $87.82 $3.31 Million - $4.1 Million	-46,700 Closed	0 $0
Q2 2019 Aug 12, 2019	BUY	$65.86 - $92.79 $3.08 Million - $4.33 Million	46,700 New	46,700 $3.39 Million
Q2 2018 Aug 08, 2018	SELL	$88.31 - $107.8 $927,255 - $1.13 Million	-10,500 Closed	0 $0
Q1 2018 May 10, 2018	BUY	$115.92 - $148.54 $1.22 Million - $1.56 Million	10,500 New	10,500 $1.25 Million

644

109M

1.28M

1.21M

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $30.9B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

Get notified when there are updates to the investment portfolio of Spark Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Spark Investment Management LLC with notifications on news.